Pasritamig

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Study of Tagmokitug in Combination With Other Treatments in Participants With Advanced or Metastatic Solid TumorsNCT07945821CHRSPhase 1, Phase 2Recruiting2028-08Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.